Radiomics of Tumor Heterogeneity in (18)F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: Biomarkers reliably predicting treatment response to immune checkpoint inhibition (CKI) therapy in advanced non-small cell lung cancer (NSCLC) are warranted. Baseline (18)F-FDG-PET-CT (PET-CT) is an integral part of the diagnostic algorithm of NSCLC. However, there is poor evidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventura, David, Schindler, Philipp, Masthoff, Max, Görlich, Dennis, Dittmann, Matthias, Heindel, Walter, Schäfers, Michael, Lenz, Georg, Wardelmann, Eva, Mohr, Michael, Kies, Peter, Bleckmann, Annalen, Roll, Wolfgang, Evers, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136892/
https://www.ncbi.nlm.nih.gov/pubmed/37190228
http://dx.doi.org/10.3390/cancers15082297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136892/
https://www.ncbi.nlm.nih.gov/pubmed/37190228
http://dx.doi.org/10.3390/cancers15082297

Ejemplares similares